Transforming Healthcare with Precision Bioelectric Therapies
Electrome is dedicated to advancing the human condition with precision bioelectric therapies that work with the body’s natural electrical code.
Our Approach & Team
Electrome is building a unified discovery and delivery platform for next-generation therapies. Our system combines AI-driven modeling, digital twin simulations, and real-world lab validation to decode how bioelectric patterns influence biology. These therapies are designed to stand alone or enhance existing care options, including traditional treatments used today such as chemical-based therapies and other established clinical approaches. Our vision is to usher in a new era of medicine that seamlessly integrates bioelectric therapies into the broader landscape of healthcare and wellness.
Our team is structured to ensure no gaps from discovery through delivery. It includes world-class researchers, medical scientists, clinical advisors, product development specialists, commercialization leaders, regulatory strategists, and intellectual property experts. This balance of expertise ensures we can translate scientific discovery into scalable, real-world solutions with speed and rigor. Together, we are building a company with a clear mission, strong vision, and the leadership required to transform healthcare globally.
Our Team
Ken Mayer
CEO
Founder and former CEO of Safe Health (partnership with Mayo Clinic generated $150M in first 5 years); Serial entrepreneur with 3 exits (combined $180M).
Nev Zubcevik, DO
Chief Medical Officer
Harvard-trained physician driving brain-focused R&D, past CMO of SofPulse, leading innovator in brain MedTech. Experienced CMO leading critical brain-recovery MedTech.
Erik A. Nilsen, PhD
CTO
Physicist & elec engr w/ expertise in biophysics & electrophysiology. Advisor/contributor to DoD, DARPA & industry; built numerous bioelectric recording & stimulation systems over 20+ years, patents & publications in bioelectric domain; 3 exits.
Wanni Davis, PhD, MBA
COO
Former director of Industry Partnerships at Harvard-affiliated Hospitals; biotech strategist with 15+ years in translational science, venture development, and commercialization; leading partnerships, BD, and alliance operations across the life sciences/biopharma ecosystem
Samir S. Awad, MD
Medical Director
Chief of Surgery at Houston VA hospital/Baylor College of Medicine . Expert in FDA strategy, clinical research, and non-invasive therapeutic development across pain, wound, and edema fields.
Shari Nastasi, PharmD
Chief Marketing Officer
Neuroimmunology expert with 30+ years advancing brain and immune health therapies. Certified in Neurology, Immunology, Nutrition, and Pharmacogenomics. Published in encephalopathy, brain trauma, and immunology research.
Our Guiding Principals
Lead with Biology to Improve Chemistry
We create therapies that work with the body’s native electrical systems—targeting the root cause, not just the symptoms, through precision bioelectric signaling.
Prove It or Don’t Ship It
Every therapy we develop must be grounded in rigorous science, validated by data, and deliver measurable outcomes—no hype, just evidence.
Engineer for Impact
From discovery to deployment, we build technologies that scale—so the right therapy can reach the right patient, at the right time, anywhere in the world.
Let’s Join Forces to Transform the Future of Medicine
We partner across sectors to bring breakthrough therapies to life—accelerating discovery, access, and real-world impact through science-driven collaboration. Whether you’re a researcher, nonprofit, government agency, payer, or global pharma, we would love to hear from you.
